| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C031903 |
1-UFT protocol |
CLDN3 protein results in increased susceptibility to 1-UFT protocol | increases response to substance | 16734730
|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CLDN3 mRNA | affects expression | 21346803
|
| C026137 |
3-hydroxyacetanilide |
3-hydroxyacetanilide results in decreased expression of CLDN3 mRNA | decreases expression | 18544908
|
| C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of CLDN3 mRNA | decreases expression | 18648102
|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of CLDN3 mRNA | affects expression | 17562736
|
| D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of CLDN3 mRNA | decreases expression | 18544908
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CLDN3 mRNA | affects expression | 16483693
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of CLDN3 mRNA | decreases expression | 20106945
|
| C095105 |
bexarotene |
bexarotene results in increased expression of CLDN3 mRNA | increases expression | 16648578
|
| C110904 |
capecitabine |
CLDN3 protein results in increased susceptibility to capecitabine | increases response to substance | 16734730
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CLDN3 mRNA | decreases expression | 20106945
|
| C014347 |
decitabine |
[decitabine co-treated with trichostatin A] inhibits the reaction [MBD2 protein binds to CLDN3 promoter] | affects binding|affects cotreatment|decreases reaction | 17986852
|
| C014347 |
decitabine |
[decitabine co-treated with trichostatin A] promotes the reaction [SP1 protein binds to CLDN3 promoter] | affects binding|affects cotreatment|increases reaction | 17986852
|
| C014347 |
decitabine |
[decitabine co-treated with trichostatin A] promotes the reaction [SP3 protein binds to CLDN3 promoter] | affects binding|affects cotreatment|increases reaction | 17986852
|
| C014347 |
decitabine |
decitabine inhibits the reaction [MBD2 protein binds to CLDN3 promoter] | affects binding|decreases reaction | 17986852
|
| C014347 |
decitabine |
decitabine promotes the reaction [SP1 protein binds to CLDN3 promoter] | affects binding|increases reaction | 17986852
|
| C014347 |
decitabine |
decitabine promotes the reaction [SP3 protein binds to CLDN3 promoter] | affects binding|increases reaction | 17986852
|
| C014347 |
decitabine |
decitabine results in increased expression of CLDN3 mRNA | increases expression | 16367923 17986852
|
| C014347 |
decitabine |
decitabine results in increased expression of CLDN3 protein | increases expression | 17986852
|
| C014347 |
decitabine |
trichostatin A promotes the reaction [decitabine results in increased expression of CLDN3 mRNA] | increases expression|increases reaction | 17986852
|
| C014347 |
decitabine |
trichostatin A promotes the reaction [decitabine results in increased expression of CLDN3 protein] | increases expression|increases reaction | 17986852
|
| C121718 |
dicyclanil |
dicyclanil results in increased expression of CLDN3 mRNA | increases expression | 15664270
|
| D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in decreased expression of CLDN3 mRNA | decreases expression | 15149470
|
| C025034 |
doxifluridine |
CLDN3 protein results in increased susceptibility to doxifluridine | increases response to substance | 16734730
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CLDN3 mRNA | increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CLDN3 mRNA | affects cotreatment|decreases expression | 17942748
|
| D017313 |
Fenretinide |
Fenretinide results in increased expression of CLDN3 mRNA | increases expression | 16671099
|
| D007529 |
Isoflavones |
Isoflavones results in decreased expression of CLDN3 mRNA | decreases expression | 17374662
|
| C011890 |
kojic acid |
kojic acid results in decreased expression of CLDN3 mRNA | decreases expression | 16595896
|
| D015741 |
Metribolone |
Metribolone results in increased expression of CLDN3 mRNA | increases expression | 17010196
|
| D015735 |
Mifepristone |
Mifepristone inhibits the reaction [Progesterone results in decreased expression of CLDN3 protein] | decreases expression|decreases reaction | 17478549
|
| D017239 |
Paclitaxel |
CLDN3 protein results in decreased susceptibility to Paclitaxel | decreases response to substance | 16734730
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CLDN3 mRNA | affects binding|decreases expression|increases activity | 19710929
|
| C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CLDN3 mRNA | decreases expression | 18445702
|
| D011374 |
Progesterone |
Progesterone affects the expression of CLDN3 mRNA | affects expression | 17251523
|
| D011374 |
Progesterone |
Mifepristone inhibits the reaction [Progesterone results in decreased expression of CLDN3 protein] | decreases expression|decreases reaction | 17478549
|
| D011374 |
Progesterone |
Progesterone results in decreased expression of CLDN3 protein | decreases expression | 17478549
|
| C079198 |
S 1 (combination) |
CLDN3 protein results in increased susceptibility to S 1 (combination) | increases response to substance | 16734730
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CLDN3 mRNA | affects cotreatment|decreases expression | 17942748
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CLDN3 mRNA | increases expression | 16960034
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CLDN3 mRNA | decreases expression | 16054898
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CLDN3 mRNA | increases expression | 16960034
|
| C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] inhibits the reaction [MBD2 protein binds to CLDN3 promoter] | affects binding|affects cotreatment|decreases reaction | 17986852
|
| C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] promotes the reaction [SP1 protein binds to CLDN3 promoter] | affects binding|affects cotreatment|increases reaction | 17986852
|
| C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] promotes the reaction [SP3 protein binds to CLDN3 promoter] | affects binding|affects cotreatment|increases reaction | 17986852
|
| C012589 |
trichostatin A |
trichostatin A promotes the reaction [decitabine results in increased expression of CLDN3 mRNA] | increases expression|increases reaction | 17986852
|
| C012589 |
trichostatin A |
trichostatin A promotes the reaction [decitabine results in increased expression of CLDN3 protein] | increases expression|increases reaction | 17986852
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.64 | 15322242 11752688 14514962 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.35 | 18287403 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.73 | 17505938 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.92 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.82 | 20127859 20464547 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.82 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
6.82 | 10697514 |
| MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.19 | 3712494 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.19 | 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
dicyclanil |
16.21 | 17162532 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
16.21 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
16.21 | 16835633 |
| MESH:D000505 |
Alopecia |
|
Isoflavones |
4.55 | 17569567 |
| MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.28 | 15469931 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.76 | 11748828 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.63 | 10982225 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.87 | 19183758 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.26 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.54 | 15885639 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
| MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.81 | 11289319 1440618 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.14 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.14 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.58 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.63 | 15746008 |
| MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.37 | 15867366 |
| MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.13 | 17868700 |
| MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.05 | 15845082 15380490 15665606 |
| MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.17 | 16187019 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
5.62 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
5.62 | 16818667 16344269 |
| MESH:D001943 |
Breast Neoplasms |
|
capecitabine |
5.62 | 12972520 18473752 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
5.62 | 19208741 18320071 |
| MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
5.62 | 15324884 17129689 |
| MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
5.62 | 16601279 |
| MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
5.62 | 18223236 11325840 18234424 16115903 16244791 15136595 16273361 18323546 |
| MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
5.62 | 16175315 15562024 17614352 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.62 | 20435547 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.63 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
13.55 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
13.55 | 7296757 3581430 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
13.55 | 3084413 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
dicyclanil |
13.55 | 17162532 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
13.55 | 16924424 15948411 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
13.55 | 16270382 17159502 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
13.55 | 16313753 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
6.01 | 16247446 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
S 1 (combination) |
6.01 | 18212800 18347146 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.58 | 7296757 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.40 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
10.40 | 19215824 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
10.40 | 16274795 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
S 1 (combination) |
10.40 | 15984520 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.25 | 16120746 18850075 18670907 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Isoflavones |
4.01 | 17689850 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
2.46 | 10977129 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.10 | 7505956 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.10 | 12371664 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
5.26 | 16154183 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
17.95 | 19486331 9022650 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
17.95 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
17.95 | 17681005 11677210 16919318 16105132 17333356 15861022 17110522 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
17.95 | 19176532 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.02 | 15340226 8697196 16354765 12621046 15668235 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.30 | 17616700 |
| MESH:D015179 |
Colorectal Neoplasms |
|
capecitabine |
6.31 | 18448328 18473752 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
6.31 | 18981723 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
6.31 | 17273769 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Isoflavones |
6.31 | 17116718 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
6.31 | 18802399 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.88 | 17141729 14669216 |
| MESH:D003329 |
Coronary Vasospasm |
|
capecitabine |
5.61 | 17465463 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 20055451 15322242 10048152 |
| MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.35 | 12952375 16002989 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.81 | 18551238 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.61 | 14531868 12868966 11298694 18759878 8970840 11906362 2524372 8156756 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.33 | 18249437 |
| MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.30 | 2952479 3621924 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.62 | 17107852 |
| MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.28 | 17187935 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.41 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.41 | 16192314 9022650 6679447 6482804 18692083 8291058 18289764 1440618 9653073 9328219 18648102 11289319 7440962 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.41 | 11739529 11461765 19923254 18071297 2444490 11834606 15619225 16227642 16081117 17906064 16177239 11287661 19164858 14986274 10774834 12705907 19420014 12958197 17562736 10915739 19085960 17522070 12392966 11421492 15968718 12540782 16393943 12153990 18713872 11529661 12594235 14550746 16485898 16781746 16109766 14725611 11743745 19416960 19370779 10663392 19739265 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.41 | 20420201 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.89 | 19426721 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.61 | 11462148 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
5.92 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.92 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.69 | 15322242 16714409 18230668 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.36 | 12538720 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
8.36 | 17692515 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
13.32 | 19294695 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
13.32 | 19294695 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
4.48 | 16402032 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
3.33 | 15700306 16804899 |
| MESH:D004715 |
Endometriosis |
|
Mifepristone |
14.27 | 16134523 |
| MESH:D004715 |
Endometriosis |
|
Progesterone |
14.27 | 16134523 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
14.27 | 9294722 10568697 |
| MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.97 | 3581430 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.97 | 16530937 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
6.97 | 16481741 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.86 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
11.90 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
11.90 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
11.90 | 20131406 19236843 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.53 | 16534752 16513791 15751030 16002989 16611131 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.25 | 11858732 |
| MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.81 | 6705139 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
7.79 | 12639820 12168785 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.79 | 20067830 |
| MESH:D005706 |
Gallbladder Neoplasms |
|
S 1 (combination) |
5.56 | 19093184 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.46 | 16983495 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.74 | 16452187 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.01 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Fenretinide |
7.30 | 16187019 |
| MESH:D005909 |
Glioblastoma |
|
trichostatin A |
7.30 | 18801729 |
| MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.84 | 7505956 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.38 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.94 | 19215824 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
S 1 (combination) |
7.94 | 18607998 15984520 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.08 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.08 | 10048152 11294989 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.41 | 20558911 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.21 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.15 | 11000095 |
| MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.31 | 6705139 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.57 | 19772884 18467677 19176532 16221962 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.57 | 16120746 15340226 12621046 |
| MESH:D019584 |
Hot Flashes |
|
Isoflavones |
4.77 | 14716179 17290160 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.83 | 18606429 15340226 8697196 16959395 16354765 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.54 | 16870215 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.00 | 20558911 |
| MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
10.14 | 15034207 |
| MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
10.14 | 12960047 14722030 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.68 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.68 | 18670907 18850075 |
| MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
10.55 | 16002989 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
10.55 | 16945680 16569931 |
| MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.19 | 15869954 |
| MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.15 | 15036965 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.27 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
6.26 | 17581917 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.26 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Progesterone |
4.62 | 15869954 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.62 | 12200463 12878042 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.50 | 16306350 |
| MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.81 | 8074119 9022650 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.15 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.23 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.40 | 15629191 12587719 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.40 | 8314463 10903974 18776723 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
16.36 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
16.36 | 6582329 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
16.36 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
16.36 | 16762066 15003126 14681315 |
| MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.86 | 17184923 |
| MESH:D007938 |
Leukemia |
|
decitabine |
2.97 | 19235587 18980019 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
3.81 | 18454857 19117987 17236224 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.14 | 19387464 18704418 17679729 18206229 19010910 18460780 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.14 | 18206229 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.25 | 18055864 |
| MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.83 | 16707609 |
| MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.63 | 17353645 |
| MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.07 | 9327722 15034207 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.07 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.07 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.58 | 19460945 12587719 19784758 16611625 19014921 16610002 12969438 11587558 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.05 | 17185352 16871587 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
13.40 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
dicyclanil |
13.40 | 20118626 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
13.40 | 16712894 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
13.40 | 20007298 15890375 16377806 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.40 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
9.13 | 1399818 6587162 598648 3712494 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
9.13 | 18544905 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.13 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.31 | 17053015 20064080 20464547 20869020 6695378 18569708 18520028 18816296 20135361 |
| MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
3.31 | 17849452 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.31 | 19555203 11884234 |
| MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.94 | 15166399 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
7.24 | 19470736 |
| MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
7.24 | 15700306 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
3.92 | 14749477 |
| MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.94 | 11161223 |
| MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.30 | 16002989 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
9.44 | 19196723 19196722 15591091 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
9.44 | 10697514 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
9.44 | 17203775 11408345 |
| MESH:D008545 |
Melanoma |
|
decitabine |
7.10 | 16505122 17785578 |
| MESH:D008545 |
Melanoma |
|
Fenretinide |
7.10 | 16270382 |
| MESH:D008545 |
Melanoma |
|
Paclitaxel |
7.10 | 12025231 12040289 16342250 |
| MESH:D008545 |
Melanoma |
|
trichostatin A |
7.10 | 16505122 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.36 | 19513568 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.58 | 16801185 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.25 | 16381670 |
| MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
8.25 | 16274795 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
11.46 | 18172295 |
| MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
11.46 | 14749477 |
| MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
11.46 | 18172295 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.30 | 16239165 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.26 | 19010910 19157545 18608210 16882708 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.06 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.85 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.79 | 16411023 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.65 | 18551238 |
| MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.28 | 3581430 |
| MESH:D009362 |
Neoplasm Metastasis |
|
capecitabine |
9.28 | 12972520 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
9.28 | 15867366 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
18.47 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
capecitabine |
18.47 | 16374040 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
18.47 | 17925555 19116145 19470736 |
| MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
18.47 | 15313581 |
| MESH:D009369 |
Neoplasms |
|
Fenretinide |
18.47 | 15958647 17353921 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
18.47 | 17405874 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.57 | 19196722 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.23 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.11 | 18481113 19348381 |
| MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
8.97 | 11399458 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.97 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.78 | 6679447 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.70 | 18514411 |
| MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.47 | 16303764 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.76 | 20558911 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.27 | 16049721 12819281 |
| MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.27 | 6482804 4026338 |
| MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.81 | 3988306 |
| MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.77 | 15867366 |
| MESH:D010024 |
Osteoporosis |
|
Isoflavones |
3.97 | 16562857 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
18.02 | 19331143 19259094 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
18.02 | 16133793 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
18.02 | 16525653 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
18.02 | 11161223 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
18.02 | 17393432 16525653 |
| MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
18.02 | 19331143 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
2.23 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.44 | 19294695 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
8.44 | 15580305 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
8.44 | 19294695 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.49 | 11578682 |
| MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.28 | 7296757 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.04 | 12520081 |
| MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.26 | 6228378 |
| MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.96 | 14722030 |
| MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.46 | 16977796 15687265 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.36 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.05 | 12371664 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
8.86 | 17184923 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.86 | 11399792 11896295 11222880 11118676 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
11.73 | 17616702 |
| MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
11.73 | 17616702 |
| MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17013881 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.90 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
1.90 | 15046698 15846301 17136230 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
1.90 | 17024972 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Isoflavones |
1.90 | 17374662 16365062 17219775 17571952 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
1.90 | 17172428 17136230 16729912 16356831 |
| MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
1.90 | 18798265 19789329 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.10 | 16919318 15861022 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.16 | 16882103 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.29 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.64 | 18990726 |
| MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
8.59 | 3692021 |
| MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
8.59 | 16303925 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.21 | 19155313 |
| MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.78 | 18045962 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.40 | 18551238 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
8.93 | 19755658 10029692 |
| MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
8.93 | 16467112 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.93 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
11.01 | 16709447 16002989 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.01 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.07 | 15862959 16503802 |
| MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 16367923 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.65 | 2093021 20155912 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
4.65 | 19037991 |
| MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
4.65 | 18506536 18396642 |
| MESH:D013274 |
Stomach Neoplasms |
|
S 1 (combination) |
4.65 | 18506536 16557585 18553229 |
| MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.60 | 16930453 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.42 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.98 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.69 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.72 | 1399818 6582329 6587162 3712494 7505956 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
6.72 | 17967635 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
18.82 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
18.82 | 8074119 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
18.82 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
18.82 | 19087683 17616700 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
18.82 | 17306315 16452187 16712894 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
18.82 | 16720286 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.10 | 10091137 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.78 | 10982225 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
9.23 | 16175088 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
9.23 | 16154183 |
| MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.96 | 14652134 |
| MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
8.80 | 16690809 15809267 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.80 | 14692618 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.70 | 17785578 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.77 | 1336536 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.23 | 16513791 16002989 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.38 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.35 | 15869587 14671159 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.04 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.23 | 17120751 |